Intra-arterial Methylprednisolone After Successful Endovascular Thrombectomy Anterior Circulation Large Vessel Occlusion
A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1060 participants.
Also called NCT07141303
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 1,060 participants
- Sponsor
- Registry
-
NCT07141303
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Recruiting
Technical summary
Registry record NCT07141303. Randomized; quadruple masking; primary purpose treatment. Start 2025-08-08 (actual); primary completion 2027-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Intra-arterial Methylprednisolone After Successful Endovascular Thrombectomy Anterior Circulation Large Vessel Occlusion
- Acronym
- IMPACT-LVO
- Condition
- Acute Ischemic Stroke
- Intervention (Drug)
- The methylprednisolone sodium succinate
- Intervention (Drug)
- Placebo
- Lead sponsor
- Tang-Du Hospital
- Collaborator
- First People's Hospital of Xianyang
- Collaborator
- First People's Hospital Of Tianshui
- Collaborator
- XD Group Hospital
- Collaborator
- Xi'an Aerospace General Hospital
- Collaborator
- First Affiliated Hospital of Chengdu Medical College
Record details
- Record id
cardio:ct-nct07141303- Content hash
634a914c42b15293a69db76a91a5f5ddd7d3d348414c12c4314385af4503e14b